On March 18, 2024, SymBio Pharmaceuticals Limited closed the transaction. The company amended the terms of the transaction and issued 1,350,000 common shares at an issue price of ¥190 per share for the gross proceeds of ¥256,500,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
156 JPY | -4.29% | -2.50% | -36.84% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.84% | 48.22M | |
+35.01% | 709B | |
+30.61% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.17% | 239B | |
+9.38% | 211B | |
-3.27% | 203B | |
+10.77% | 171B |
- Stock Market
- Equities
- 4582 Stock
- News SymBio Pharmaceuticals Limited
- SymBio Pharmaceuticals Limited amended terms of the transaction